FDA Ginseng Labeling Enforcement Stressed In House Ag Approps Bill
This article was originally published in The Tan Sheet
Executive Summary
FDA needs to take a more active approach to ensure that herbs that do not fall under the Panax genus are not labeled as "ginseng," the House Appropriations Committee states in its report on the FY 2003 Agriculture Appropriations bill
You may also be interested in...
FDA Radiation Label Change Positive, But “Material Change” Issue Troubling
FDA's proposal to revise labeling regulations for irradiated dietary supplements and food products could ease label requirements, but how the regulation would measure "material change" from radiation leaves the possibility for a bigger burden, trade groups say
Ginseng Labeling On Over 100 Firms’ Products Challenged In Calif. Lawsuit
A California group is seeking to preliminarily and permanently enjoin 107 companies from manufacturing, distributing or selling dietary supplements labeled or advertised as "ginseng" or "Siberian ginseng" that contain herbs not associated with the Panax genus
Supplement Promos To Health Professionals Merit More Flexibility – AHPA
Dietary supplement promotional speech targeted to health care practitioners should be allowed to contain substantiated disease treatment claims, the American Herbal Products Association maintains